BioCardia, Inc.
(NASDAQ : BCDA)

( )
BCDA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -1.38%147.930.0%$669.17m
AMGNAmgen, Inc. -0.79%247.731.4%$581.28m
GILDGilead Sciences, Inc. -0.68%64.741.0%$426.65m
VRTXVertex Pharmaceuticals, Inc. 0.14%294.701.9%$403.06m
REGNRegeneron Pharmaceuticals, Inc. -1.17%617.502.6%$350.73m
ILMNIllumina, Inc. -1.16%206.633.3%$303.63m
SNSSSunesis Pharmaceuticals, Inc. 0.00%4.150.7%$290.10m
NVAXNovavax, Inc. -1.10%36.7775.7%$228.83m
BIIBBiogen, Inc. -0.21%215.891.8%$185.14m
BNTXBioNTech SE -1.15%145.920.0%$149.13m
SAVACassava Sciences, Inc. 0.11%26.500.0%$120.35m
GOVXGeoVax Labs, Inc. -6.09%1.850.0%$98.47m
BMRNBioMarin Pharmaceutical, Inc. -0.50%92.504.2%$97.46m
CRSPCRISPR Therapeutics AG -1.59%71.000.6%$89.67m
EXASEXACT Sciences Corp. -1.48%37.9117.6%$82.80m

Company Profile

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brands. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.